1. Subramanian G, McAfee JG, Bell EG, Blair RJ, O'Mara RE, Ralston PH. 99m Tc-labeled polyphosphate as a skeletal imaging agent. Radiology. 1972; 102:701–4.
2. Subramanian G. Radiopharmaceuticals for bone scanning. Collier BD, Fogelman I, Rosenthall L, editors. Skeletal nuclear medicine. St. Louis (MO): Mosby;1996. p. 9–20.
3. Freeman LM, Blaufox MD. Letter from the Editors: planar imaging in the age of SPECT. Semin Nucl Med. 2012; 42:1–2.
Article
4. Davila D, Antoniou A, Chaudhry MA. Evaluation of osseous metastasis in bone scintigraphy. Semin Nucl Med. 2015; 45:3–15.
Article
5. Brenner AI, Koshy J, Morey J, Lin C, DiPoce J. The bone scan. Semin Nucl Med. 2012; 42:11–26.
Article
6. Palestro CJ. Radionuclide imaging of osteomyelitis. Semin Nucl Med. 2015; 45:32–46.
Article
7. Scharf SC. Bone SPECT/CT in skeletal trauma. Semin Nucl Med. 2015; 45:47–57.
Article
8. Palestro CJ. FDG-PET in musculoskeletal infections. Semin Nucl Med. 2013; 43:367–76.
Article
9. Jadvar H, Desai B, Conti PS. Sodium 18F-fluoride PET/CT of bone, joint, and other disorders. Semin Nucl Med. 2015; 45:58–65.
Article
10. Fischer DR. Musculoskeletal imaging using fluoride PET. Semin Nucl Med. 2013; 43:427–33.
Article
11. Jones AG, Francis MD, Davis MA. Bone scanning: radio-nuclidic reaction mechanisms. Semin Nucl Med. 1976; 6:3–18.
Article
12. Elgazzar AH. Orthopedic nuclear medicine. Berlin: SpringerVerlag;2004. p. 13–31.
13. Lee WW, So Y. Skeletal system. In: Chung JK, Lee MC. Nuclear medicine. 3rd ed.Seoul: Korea Medical Book Publisher;2008. p. 509–71.
14. Eggli DF, Tulchinsky M. Normal planar bone scan. Collier BD, Fogelman I, Rosenthall L, editors. Skeletal nuclear medicine. St. Louis (MO): Mosby;1996. p. 25–6.
15. Grassi W, De Angelis R, Lamanna G, Cervini C. The clinical features of rheumatoid arthritis. Eur J Radiol. 1998; 27(Suppl 1):S18–24.
Article
16. Ziff M. General mechanisms of inflammation in rheumatoid arthritis. Bull Schweiz Akad Med Wiss. 1979; 35:275–81.
17. Kim JY, Choi YY, Kim CW, Sung YK, Yoo DH. Bone scintigraphy in the diagnosis of rheumatoid arthritis: is there additional value of bone scintigraphy with blood pool phase over conventional bone scintigraphy? J Korean Med Sci. 2016; 31:502–9.
Article
18. Elgazzar AH, Silberstein EB. Skeletal scintigraphy in non-neoplastic osseous disorders. Henkin RE, Bova D, Dilehay GL, Halama JR, Karesh SM, Wagner RH, editors. Nuclear medicine. 2nd ed.Philadelphia (PA): Mosby;2006. p. 1121–81.
19. Rosenthall L. Nuclear medicine techniques in arthritis. Rheum Dis Clin North Am. 1991; 17:585–97.
Article
20. Chalmers J, Gray DH, Rush J. Observations on the induction of bone in soft tissues. J Bone Joint Surg Br. 1975; 57:36–45.
Article
21. Craven PL, Urist MR. Osteogenesis by radioisotope labelled cell populations in implants of bone matrix under the influence of ionizing radiation. Clin Orthop Relat Res. 1971; 76:231–43.
Article
22. Oh SN, Jee WH, Cho SM, Kim SH, Kang HS, Ryu KN, et al. Osteonecrosis in patients with systemic lupus erythematosus: MR imaging and scintigraphic evaluation. Clin Imaging. 2004; 28:305–9.
23. Ostendorf B, Mattes-György K, Reichelt DC, Blondin D, Wirrwar A, Lanzman R, et al. Early detection of bony alterations in rheumatoid and erosive arthritis of finger joints with high-resolution single photon emission computed tomography, and differentiation between them. Skeletal Radiol. 2010; 39:55–61.
Article
24. McQueen FM. Imaging in early rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2013; 27:499–522.
Article
25. Zilber K, Gorenberg M, Rimar D, Boulman N, Kaly L, Rozenbaum M, et al. Radionuclide methods in the diagnosis of sacroiliitis in patients with spondyloarthritis: an update. Rambam Maimonides Med J. 2016; 7:e0037.
Article
26. Caldarella C, Isgrò MA, Treglia I, Treglia G. Is fluorine-18-fluorodeoxyglucose positron emission tomography useful in monitoring the response to treatment in patients with multiple myeloma? Int J Hematol. 2012; 96:685–91.
Article
27. Love C, Tomas MB, Tronco GG, Palestro CJ. FDG PET of infection and inflammation. Radiographics. 2005; 25:1357–68.
Article
28. Chaudhari AJ, Ferrero A, Godinez F, Yang K, Shelton DK, Hunter JC, et al. High-resolution (18)F-FDG PET/CT for assessing disease activity in rheumatoid and psoriatic arthritis: findings of a prospective pilot study. Br J Radiol. 2016; 89:20160138.
29. Dhawan R, Lokitz K, Lokitz S, Caldito G, Takalkar AM. FDG PET imaging of extremities in rheumatoid arthritis. J La State Med Soc. 2016; 168:156–61.
30. Suto T, Okamura K, Yonemoto Y, Okura C, Tsushima Y, Takagishi K. Prediction of large joint destruction in patients with rheumatoid arthritis using 18F-FDG PET/CT and disease activity score. Medicine (Baltimore). 2016; 95:e2841.
Article
31. Yonemoto Y, Okamura K, Takeuchi K, Kaneko T, Kobayashi T, Okura C, et al. [18F]fluorodeoxyglucose uptake as a predictor of large joint destruction in patients with rheumatoid arthritis. Rheumatol Int. 2016; 36:109–15.
Article
32. Wakura D, Kotani T, Takeuchi T, Komori T, Yoshida S, Makino S, et al. Differentiation between Polymyalgia Rheumatica (PMR) and elderly-onset rheumatoid arthritis using 18F-fluorodeoxyglucose positron emission tomography/computed tomography: is enthesitis a new pathological lesion in PMR? PLoS One. 2016; 11:e0158509.
Article
33. Li Y, Schiepers C, Lake R, Dadparvar S, Berenji GR. Clinical utility of (18)F-fluoride PET/CT in benign and malignant bone diseases. Bone. 2012; 50:128–39.
Article
34. Czernin J, Satyamurthy N, Schiepers C. Molecular mechanisms of bone 18F-NaF deposition. J Nucl Med. 2010; 51:1826–9.
Article
35. Kim JY, Choi YY, Kim YH, Park SB, Jeong MA. Role of (18)F-fluoride PET/CT over dualphase bone scintigraphy in evaluation and management of lesions causing foot and ankle pain. Ann Nucl Med. 2015; 29:302–12.
Article